
浏览全部资源
扫码关注微信
纸质出版日期:2015
移动端阅览
柴连海, 王丽丽, 陈文生. 黄芪及其活性成分黄芪多糖对心衰模型小鼠同型半胱氨酸、核因子-B和-二聚体水平的影响[J]. 中国实验方剂学杂志, 2015,21(17):142-145.
CHAI Lian-hai, WANG Li-li, CHEN Wen-sheng. Effect of Astragali Radix and Its Active Ingredient Astragalus Polysaccharideits on Homocysteine, NF-B and -Dimer in Heart Failure Model Mice[J]. Chinese journal of experimental traditional medical formulae, 2015, 21(17): 142-145.
柴连海, 王丽丽, 陈文生. 黄芪及其活性成分黄芪多糖对心衰模型小鼠同型半胱氨酸、核因子-B和-二聚体水平的影响[J]. 中国实验方剂学杂志, 2015,21(17):142-145. DOI: 10.13422/j.cnki.syfjx.2015170142.
CHAI Lian-hai, WANG Li-li, CHEN Wen-sheng. Effect of Astragali Radix and Its Active Ingredient Astragalus Polysaccharideits on Homocysteine, NF-B and -Dimer in Heart Failure Model Mice[J]. Chinese journal of experimental traditional medical formulae, 2015, 21(17): 142-145. DOI: 10.13422/j.cnki.syfjx.2015170142.
目的: 探究中药黄芪及其活性成分黄芪多糖对心衰模型小鼠同型半胱氨酸(Hcy)
核因子-κB(NF-κB)和D-二聚体(D-D)水平的影响。 方法: SPF级雄性小鼠100只
随机选取20只为正常组
另80只ip异丙肾上腺素建立心衰模型
造模成功后分为黄芪组(3 g·kg-1)
黄芪多糖组(3 g·kg-1)
阳性药组(地高辛
0.05 mg·kg-1)和模型组
每组各20只
黄芪组以3 mL·kg-1·d-1剂量ig黄芪提取物原液
黄芪多糖组按3 g·kg-1·d-1剂量ip
阳性药组以0.05 mg·kg-1·d-1剂量ig地高辛
模型组无菌生理盐水3 mL·kg-1·d-1 ig
ip与ig均为日1次
连续干预4周后
取其心尖部心肌组织进行病理学检查
腹主动脉取血进行Hcy
NF-κB和D-D水平的检测。 结果: 与正常组比较
模型组Hcy
NF-κB和D-D水平明显升高(P<0.05)
病理结果 显示模型组心肌纤维数量减少
染色变浅
横纹模糊
部分坏死灶被瘢痕组织代替;与模型组比较
各给药组Hcy
NF-κB和D-D 水平明显降低(P<0.05)
病理结果显示各给药组心尖部心肌组织坏死病灶明显减轻;与黄芪组及地高辛组比较
黄芪多糖组效果更明显。 结论: 中药黄芪及其活性成分黄芪多糖对心衰模型小鼠Hcy
NF-κB和D-D有明显的降低作用
但后者的作用效果好于前者。
Objective: To explore the effect of Astragali Mongolici Radix and its active ingredient Astragali Mongolici Radix polysaccharideits on the expressions of homocysteine(Hcy)
nuclear factor(NF-κB) and D-dimer(D-D) in heart failure model mice. Method: Totally 100 SPF male mice were divided into the normal group (20 mice) and the model group (80 mice) by random. The heart failure mice model was induced through the intraperitoneal injection with isoproterenol. After the successful modeling
they were randomly divided into the RA group (Astragali Mongolici Radix
3 g·kg-1)
the APS group (Astragali Mongolici Radix polysaccharideits
3 g·kg-1)
the positive medicine group (Digoxin
0.05 mg·kg-1) and the model group
with 20 mice in each group. The RA group was orally given 3 mL·kg-1·d-1 Astragali Mongolici Radix extract liquid (1 g·mL-1);the APS group was intraperitoneally injected with 3 mL·kg-1·d-1 of Astragali Mongolici Radix polysaccharide;the positive drug group was orally given 0.05 mL·kg-1·d-1 of digoxin;the model control group was orally given 3 mL·kg-1·d-1 of sterile saline. All of them were treated for 4 weeks. After the experiment
their apex cordis and myocardial tissues were collected for pathological examination. The blood was drawn from abdominal arteries for detecting the expressions of Hcy
NF-κB and D-D. Result: The expressions of Hcy
NF-κB and D-D in the model group were higher than that of the normal group (P<0.05). According to the pathological results
the model group showed less myocardial fiber
lighter staining
vague bands and partial replacement of necrotic lesions with scar tissues. Compared with the model group
all of treatment groups showed obvious reductions in Hcy
NF-κB and D-D levels (P<0.05). The pathological results also showed significant reduction in necrotic lesions in apex cordis and myocardial tissues in all of treatment groups. Compared with the RA group and the Digoxin group
the APS showed more significant effects. Conclusion: Astragali Mongolici Radix and its active ingredient APS could obviously reduce the expressions of Hcy
NF-κB and D-D in mice with heart failure;but the latter drug has a better effect than the former.
0
浏览量
4
下载量
3
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621